Krishnan K. Mahadevan, Ana S. Maldonado, Bingrui Li, Aaron A. Bickert, Adrian Kacperczyk-Perdyan, Shreyasee V. Kumbhar, Sujan Piya, Amari M. Sockwell, Sami J. Morse, Kent Arian, Hikaru Sugimoto, Shabnam Shalapour, David S. Hong, Timothy P. Heffernan, Anirban Maitra, Raghu Kalluri. "Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer." Nature Communications, 2026. doi:10.1038/s41467-026-75960-3